The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Esraa M. Halawa, Sherihan G. AbdelHamid, Mahmoud ElHefnawi. Oncolytic virotherapy for cancer: biological mechanisms, clinical advances, and future perspectives, Clinical and Experimental Medicine. 2026; 26: 358. https://doi.org/10.1007/s10238-026-02311-3 |
|
2 |
2026 |
Victor Arias, James H Clubb, Tatiana V Kudling, Elise Jirovec, Santeri Artturi Pakola, Lyna Haybout, Dafne C A Quixabeira, Mirte van der Heijden, Nea Ojala, Susanna Grönberg-Vähä-Koskela, Sini Raatikainen, Michael J Chisamore, Katriina Jalkanen, Tuomo Alanko, Jukka Kemppainen, Maria Hellesuo, Anniina Färkkilä, Matthew Stephen Block, Tine Juul Monberg, Inge Marie Svane, Johanna Mäenpää, Suvi Sorsa, Claudia Kistler, João Manuel dos Santos, Anna Kanerva, Otto Hemminki, Victor Cervera-Carrascon, Akseli Hemminki. Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy, Journal for ImmunoTherapy of Cancer. 2026; 14: e016430. https://doi.org/10.1136/jitc-2026-016430 |
|
3 |
2026 |
Cillian H. Cheng, Chi Chun Wong. The mycobiome, virome and archaeome in gastrointestinal cancers: molecular pathogenesis and therapeutic intervention, Molecular Cancer. 2026; 25: 182. https://doi.org/10.1186/s12943-026-02698-3 |
|
4 |
2026 |
Mohammad Fayyad-Kazan, Sarah Al-Tameemi, Allal Ouhtit. Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation, Cells. 2026; 15: 393. https://doi.org/10.3390/cells15050393 |
|
5 |
2026 |
Selvakumar Muruganantham, Shanmugarathinam Alagarsamy, Dhanalakshmi Mohanaradj. Virus-based therapeutic platforms, Precision and Future Medicine. 2026; 10: 121. https://doi.org/10.23838/pfm.2026.00128 |
|
6 |
2026 |
Omid Salahi Ardekani, Mahya Zarezade, Behshid Meymandi, Narjes Azami, Bahar Mahdavi, Toran Shahani. Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies, Virology Journal. 2026; 23: 187. https://doi.org/10.1186/s12985-026-03207-0 |
|
7 |
2026 |
André Mansinho, Joana Albuquerque, Emiliano Calvo. Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunity, The Lancet Regional Health - Europe. 2026; 64: 101659101659. https://doi.org/10.1016/j.lanepe.2026.101659 |
|
8 |
2026 |
Tanya Saxena, Shamsuz Zaman, Himanshu Dhanda, Sandeep Kumar Swain, Neetu Kushwaha, Manpreet Kaur, Raj Kamal, Sufian Zaheer, Pranay Tanwar, Neeraj Kumar, Fouzia Siraj, Bhavika Rishi, Aroonima Misra. Immunotherapy for Cancer: Current Advances and Future Directions, International Journal of Molecular Sciences. 2026; 27: 7216. https://doi.org/10.3390/ijms27167216 |
|
9 |
2026 |
Subham Das, Himakshi Rekha Goswami, Indrani Barman, Nayan Talukdar. Efficacy of oncolytic viruses (OVs) in malignant tumor therapy: a review on its therapeutic aspects, Clinica Chimica Acta. 2026; 589: 121017121017. https://doi.org/10.1016/j.cca.2026.121017 |
|
10 |
2026 |
Saira Zulfiqar, Xiaoyan Wang, Baofu Chen, Yigang Wang. The future of cancer therapy? Integrating oncolytic adenoviruses with epigetic modulation, Epigenomics. 2026; 18: 1249. https://doi.org/10.1080/17501911.2026.2739787 |